comparemela.com

Latest Breaking News On - Disease modifying antirheumatic drugs - Page 1 : comparemela.com

Most RA Patients Meet EMA s JAK Inhibitor Warning Criteria

Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.

Newcastle upon tyneUnited kingdomGlasgow cityBristol myers squibbKen bakerPeter taylorEli lillySamsung bioepisNorman collissonMaya buchPaul emeryIain mcinnesBritish society for rheumatologyDrug administrationLeeds biomedical research centreUniversity of manchester

Lower CVD Risk With Stable DMARD Therapy in Seropositive RA

Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.

Eirik ikdahlNorwegian cardio rheuma registerMusculoskeletal diseasesDiakonhjemmet hospitalRheumatoid arthritis raHeumatoid arthritis raAcute strokeDisease modifying antirheumatic drugsOint inflammationAcute coronary syndrome acsAcute coronary syndrome acsHeart failureCv riskCardiovascular riskV risk factorsCardiovascular risk factors

AbbVie raises full year profit guidance as Humira sales fall

Sales of the pharma giant's newer drugs are offsetting its Humira losses.

Roberta michaelRicharda gonzalezWall streetDisease modifying antirheumatic drugsPharmaceutical industryBbvie sRicharda gonzalezJohn mccaffertyRoberta michael

Investigators Train AI Systems to Predict RA Outcomes

Plugging massive amounts of data from EHRs into AI systems may turn masses of silicon chips into crystal balls for foretelling treatment efficacy.

New yorkUnited statesHospital for special surgeryJinoos yazdanyInformatics labRheumatoid arthritis research summit raStanford universityArthritis foundationUniversity of california san franciscoHealth assessment questionnaireZuckerberg san francisco general hospitalCalifornia san franciscoArthritis research summitSpecial surgeryNew york cityHealth assessment

Body Fat Tied to Disease Burden in Biologic-Treated axSpA

Maintaining a healthy body composition is important to improve physical functioning and mobility in patients with axial spondyloarthritis receiving biologics, a new study indicated.

Valeria rios rodriguezGerman spondyloarthritis inception cohortAnkylosing spondylitis disease activity indexAxial spondyloarthritis disease activity scoreBath ankylosing spondylitis functional indexBath ankylosing spondylitis mobility indexAxial spondyloarthritis axspaAnkylosing spondylitisHeumatoid spondylitisHeumatoid arthritis of the spineEchterew 039s diseaseEchterew syndromeMarie strumpell diseaseArie struempell diseaseDisease modifying antirheumatic drugsBiologic therapy

vimarsana © 2020. All Rights Reserved.